Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-15T06:52:41.937Z Has data issue: false hasContentIssue false
  • English
  • Français

The Ethics and Feasibility of Randomized Trials of Diagnostic Technology: A Reply

Published online by Cambridge University Press:  10 March 2009

Gordon H. Guyatt  and
Michael F. Drummond
Gordon H. Guyatt
Affiliation:
McMaster Health Sciences Center
Michael F. Drummond
Affiliation:
University of Birmingham
Get access Rights & Permissions [Opens in a new window]

Extract

Drs. Weinstein and Wulff (in issue 1:3) have raised legitimate and important concerns about the ethical acceptability and feasibility of randomized control trials (RCTs) of diagnostic technologies. Their criticisms are all the more compelling in light of their strong advocacy of rigorous evaluation, and their insights into the advantages of RCTs and potential problems with alternative approaches as outlined with great clarity in Dr. Weinstein's paper. We shall not attempt a point by point rebuttal (partly because we are in full or partial agreement with most of their comments) but instead will highlight several issues which we believe merit further discussion.

Type
General Essays
Information
International Journal of Technology Assessment in Health Care , Volume 1 , Issue 4 , October 1985 , pp. 901 - 903
Copyright
Copyright © Cambridge University Press 1985

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Swets, J. A., Pickett, R. M., Whitehead, S. F. et al. , Assessment of diagnostic technologies. Science. 1979, 205, 753–759.CrossRefGoogle ScholarPubMed
2.Thurow, L. C.Medicine versus economics. New England Journal of Medicine, 1985, 313, 611–615.CrossRefGoogle ScholarPubMed